Hong Kong IPO Market Raises Nearly HKD 110 Billion In Q1, Up 489% Year‑On‑Year With 40 Listings

The first quarter of 2026 witnessed a robust rebound in Hong Kong’s IPO market, delivering results that substantially exceeded market expectations. Wind data show that by March 31 a total of 40 companies listed on the Hong Kong Exchange, representing a 150% year‑on‑year increase, and collectively raised approximately HKD 110 billion, a rise of 489% from HKD 18.669 billion in the same period last year. This outcome underscores the renewed financing vitality and international appeal of the Hong Kong market.

Q1’s activity was characterized by a sharp rise in listing counts, larger deal sizes, an improved sector mix and unprecedented market enthusiasm, extending the recovery that began in 2025 and reflecting a historic surge driven by multiple favorable factors. Filing momentum remained elevated: on April 1 and April 2, seven and fourteen companies respectively submitted IPO applications or updated prospectuses. By quarter‑end, 40 IPOs had completed (39 on the Main Board and one on GEM), raising HKD 109.926 billion, a total that surpasses the full‑year proceeds of 2023 and 2024 and marks the highest quarterly level since Q2 2021. The information technology sector accounted for nearly 70% of funds raised, making it the dominant contributor.

On a global basis, Hong Kong led major markets in Q1 IPO fundraising, exceeding U.S. listings (about HKD 49.7 billion) and A‑share listings (approximately RMB 27.1 billion). Market absorption strengthened materially: the first‑day break rate for new Hong Kong listings was only 12.5%, well below the 2025 level. Several high‑profile technology listings performed strongly, with Zhipu and MiniMax seeing market capitalizations expand from roughly HKD 55 billion and HKD 90 billion to more than HKD 290 billion and HKD 300 billion respectively; Huayan Robotics recorded over 5,000 times oversubscription; Deshi Biotech rose more than 120% on debut; and Extreme Vision gained over 100% on its first trading day.

The supply pipeline also remained ample. As of March 31, 430 companies were in the listing queue, including 17 approved and awaiting listing and 413 applications under review. Q1 saw more than 233 new filings, averaging about 2.58 submissions per day and setting a quarterly record for filing volume. Three clear trends emerged alongside the scale expansion: a stronger technology tilt with new‑economy firms leading the issuance mix, a return of large‑ticket IPOs, and deeper A+H coordination with an increasing number of mainland companies choosing Hong Kong as a platform for international financing and brand building. Among the 40 completed IPOs, 15 were already listed on the A‑share market, representing 37.5% of the cohort.

This vigorous recovery reflects the confluence of institutional reforms, improved liquidity and a concentrated supply of quality issuers. Mainland companies’ ongoing financing needs, Hong Kong’s role as an international capital hub, and recent listing‑rule enhancements have together boosted market attractiveness, while a relatively accommodative global liquidity backdrop has increased international capital allocation to Hong Kong. Looking ahead, market participants expect the high IPO cadence to persist through 2026. Continued regulatory reforms at the Hong Kong Exchange, including the revised Main Board rules effective January 1 and the March 13 consultation on competitiveness, aim to lower listing thresholds, streamline processes and expand appeal. With 387 companies still under review and nine having cleared hearings across sectors such as hard technology, new consumption, biopharma and advanced manufacturing, the market’s issuance pipeline remains well stocked to support further IPO activity.